Skip to content

Artiva Biotherapeutics, Inc. ARTV Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$521.73M+526%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$594.82M+87.5%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$482.51M+936%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Computed from the period-end share price: $159.18M.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s market capitalization?
Artiva Biotherapeutics, Inc. (ARTV) reported market capitalization of $159.18M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s market capitalization changed year-over-year?
Artiva Biotherapeutics, Inc.'s market capitalization increased by 117.8% year-over-year, from $73.09M to $159.18M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.